Jennifer Hodge
Nessuna posizione attualmente
Storia della carriera di Jennifer Hodge
Precedenti posizioni note di Jennifer Hodge
Società | Posizione | Inizio | Fine |
---|---|---|---|
Nile Therapeutics, Inc. /Old/ | Corporate Officer/Principal | 17/06/1996 | 11/10/2007 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Corporate Officer/Principal | 01/01/2000 | 01/01/2007 |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Corporate Officer/Principal | 29/04/2010 | - |
CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2007 | - |
Formazione di Jennifer Hodge
The University of Edinburgh | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Nile Therapeutics, Inc. /Old/ | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Hodge
- Esperienza